(R)-adrenaline affects expression EXP 6480464 Epinephrine affects the expression of FABP3 protein CTD PMID:19464573 (R)-adrenaline multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of FABP3 protein CTD PMID:19464573 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Doxorubicin results in decreased expression of FABP3 mRNA] CTD PMID:20470772 1,1-dichloroethene decreases expression ISO RGD:69088 6480464 vinylidene chloride results in decreased expression of FABP3 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:69088 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FABP3 mRNA CTD PMID:22206623 11-deoxycorticosterone multiple interactions EXP 6480464 [Desoxycorticosterone co-treated with Sodium Chloride more ... CTD PMID:21135038 17alpha-ethynylestradiol multiple interactions ISO RGD:69088 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FABP3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:69088 6480464 Ethinyl Estradiol results in decreased expression of FABP3 mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:69088 6480464 Estradiol results in decreased expression of FABP3 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69088 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FABP3 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP3 mRNA CTD PMID:32109520 2,4-dinitrotoluene decreases expression ISO RGD:69088 6480464 2, 4-dinitrotoluene results in decreased expression of FABP3 mRNA CTD PMID:24893713 2-Ethylhexanoic acid increases expression EXP 6480464 2-ethylhexanoic acid results in increased expression of FABP3 mRNA, 2-ethylhexanoic acid results in increased expression of FABP3 protein CTD PMID:15647598 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases expression ISO RGD:69088 6480464 3 more ... CTD PMID:20512997 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69088 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP3 mRNA CTD PMID:23428407 4,4'-sulfonyldiphenol increases expression ISO RGD:69087 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FABP3 mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of FABP3 protein CTD PMID:27685785 , PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FABP3 mRNA CTD PMID:36041667 5-aza-2'-deoxycytidine affects expression ISO RGD:69087 6480464 Decitabine affects the expression of FABP3 mRNA CTD PMID:23300844 7H-xanthine multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of FABP3 protein, [Xanthine co-treated with XDH protein] results in decreased expression of FABP3 protein CTD PMID:19464573 9H-xanthine multiple interactions EXP 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of FABP3 protein, [Xanthine co-treated with XDH protein] results in decreased expression of FABP3 protein CTD PMID:19464573 aconitine increases expression EXP 6480464 Aconitine results in increased expression of FABP3 protein CTD PMID:33236894 Allylamine increases expression EXP 6480464 Allylamine results in increased expression of FABP3 protein CTD PMID:22878004 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FABP3 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FABP3 mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO RGD:69087 6480464 aristolochic acid I results in increased expression of FABP3 mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:69088 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of FABP3 mRNA CTD PMID:25270620 arsane multiple interactions ISO RGD:69088 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FABP3 mRNA CTD PMID:32045263 arsenic atom multiple interactions ISO RGD:69088 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FABP3 mRNA CTD PMID:32045263 arsenite(3-) multiple interactions ISO RGD:69088 6480464 TRP53 protein affects the reaction [arsenite results in increased expression of FABP3 mRNA] CTD PMID:18929588 arsenite(3-) increases expression ISO RGD:69088 6480464 arsenite results in increased expression of FABP3 mRNA CTD PMID:18929588 belinostat multiple interactions ISO RGD:69087 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP3 mRNA CTD PMID:27188386 benzatropine increases expression ISO RGD:69087 6480464 Benztropine results in increased expression of FABP3 protein CTD PMID:34122009 benzo[a]pyrene affects methylation ISO RGD:69087 6480464 Benzo(a)pyrene affects the methylation of FABP3 promoter CTD PMID:27901495 benzo[b]fluoranthene decreases expression ISO RGD:69088 6480464 benzo(b)fluoranthene results in decreased expression of FABP3 mRNA CTD PMID:26377693 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of FABP3 mRNA CTD PMID:17630414 bezafibrate decreases expression ISO RGD:69087 6480464 Bezafibrate results in decreased expression of FABP3 mRNA CTD PMID:15708366 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of FABP3 mRNA, Diethylhexyl Phthalate results in increased expression of FABP3 protein CTD PMID:15647598 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69088 6480464 Diethylhexyl Phthalate results in increased expression of FABP3 mRNA CTD PMID:30284816 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FABP3 mRNA, [Fructose co-treated with bisphenol A] results in increased expression of FABP3 protein CTD PMID:26930160 , PMID:36041667 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FABP3 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO RGD:69087 6480464 bisphenol A results in decreased expression of FABP3 mRNA, bisphenol A results in decreased expression of FABP3 protein CTD PMID:31715268 , PMID:34186270 bisphenol A decreases expression ISO RGD:69088 6480464 bisphenol A results in decreased expression of FABP3 mRNA CTD PMID:30951980 , PMID:35598803 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FABP3 mRNA CTD PMID:24105817 bisphenol A increases expression ISO RGD:69087 6480464 bisphenol A results in increased expression of FABP3 mRNA CTD PMID:27685785 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FABP3 mRNA CTD PMID:18180321 , PMID:25181051 Bisphenol B increases expression ISO RGD:69087 6480464 bisphenol B results in increased expression of FABP3 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FABP3 mRNA CTD PMID:36041667 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of FABP3 protein CTD PMID:28903499 cadmium dichloride decreases expression ISO RGD:69088 6480464 Cadmium Chloride results in decreased expression of FABP3 mRNA, Cadmium Chloride results in decreased expression of FABP3 protein CTD PMID:31152847 cantharidin decreases expression ISO RGD:69088 6480464 Cantharidin results in decreased expression of FABP3 mRNA CTD PMID:36907384 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of FABP3 protein CTD PMID:19854236 carbon nanotube affects expression ISO RGD:69088 6480464 Nanotubes, Carbon analog affects the expression of FABP3 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:69088 6480464 Nanotubes, Carbon results in increased expression of FABP3 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:69088 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:69087 6480464 CGP 52608 promotes the reaction [RORA protein binds to FABP3 gene] CTD PMID:28238834 chlorpyrifos increases expression ISO RGD:69088 6480464 Chlorpyrifos results in increased expression of FABP3 mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:69088 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP3 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FABP3 gene CTD PMID:20938992 chromium(6+) increases expression ISO RGD:69087 6480464 chromium hexavalent ion results in increased expression of FABP3 mRNA CTD PMID:17382205 cisplatin affects expression ISO RGD:69087 6480464 Cisplatin affects the expression of FABP3 mRNA CTD PMID:23300844 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of FABP3 mRNA CTD PMID:12851107 clofibrate increases expression ISO RGD:69088 6480464 Clofibrate results in increased expression of FABP3 mRNA CTD PMID:25270620 cobalt dichloride decreases expression ISO RGD:69087 6480464 cobaltous chloride results in decreased expression of FABP3 mRNA CTD PMID:15708366 copper atom increases expression EXP 6480464 Copper results in increased expression of FABP3 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of FABP3 mRNA CTD PMID:30556269 corilagin multiple interactions EXP 6480464 corilagin inhibits the reaction [Doxorubicin results in increased expression of FABP3 protein] CTD PMID:34369273 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of FABP3 mRNA CTD PMID:15755911 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of FABP3 protein CTD PMID:22878004 cyclosporin A decreases expression ISO RGD:69087 6480464 Cyclosporine results in decreased expression of FABP3 mRNA CTD PMID:27989131 deoxynivalenol decreases expression ISO RGD:69087 6480464 deoxynivalenol results in decreased expression of FABP3 mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO RGD:69088 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP3 mRNA CTD PMID:23428407 dexamethasone increases expression ISO RGD:69087 6480464 Dexamethasone results in increased expression of FABP3 mRNA CTD PMID:25047013 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FABP3 mRNA CTD PMID:21266533 , PMID:21745491 dichloroacetic acid decreases expression ISO RGD:69088 6480464 Dichloroacetic Acid results in decreased expression of FABP3 mRNA CTD PMID:28962523 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of FABP3 mRNA CTD PMID:21658437 dimethylarsinic acid multiple interactions ISO RGD:69088 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA CTD PMID:34876320 Diosbulbin B decreases activity ISO RGD:69088 6480464 diosbulbin B results in decreased activity of FABP3 protein CTD PMID:32148032 Diosbulbin B decreases expression ISO RGD:69088 6480464 diosbulbin B results in decreased expression of FABP3 mRNA CTD PMID:32148032 dioxygen increases expression ISO RGD:69087 6480464 Oxygen deficiency results in increased expression of FABP3 mRNA, Oxygen deficiency results in increased expression of FABP3 protein CTD PMID:24236059 , PMID:34648812 dioxygen multiple interactions ISO RGD:69087 6480464 [FV-429 compound co-treated with Paclitaxel] inhibits the reaction [Oxygen deficiency results in increased expression of FABP3 protein] CTD PMID:34648812 dioxygen multiple interactions ISO RGD:69088 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FABP3 mRNA CTD PMID:30529165 dioxygen decreases expression ISO RGD:69087 6480464 Oxygen deficiency results in decreased expression of FABP3 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:69087 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:69088 6480464 [Doxorubicin co-treated with MT2A protein] results in increased expression of FABP3 protein, sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of FABP3 protein] CTD PMID:16144979 , PMID:21251210 doxorubicin affects expression ISO RGD:69087 6480464 Doxorubicin affects the expression of FABP3 mRNA CTD PMID:29803840 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of FABP3 protein CTD PMID:28818578 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of FABP3 protein CTD PMID:32691977 , PMID:34369273 doxorubicin increases expression ISO RGD:69088 6480464 Doxorubicin results in increased expression of FABP3 protein CTD PMID:21251210 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of FABP3 mRNA CTD PMID:20470772 doxorubicin multiple interactions EXP 6480464 Carnitine inhibits the reaction [Doxorubicin results in decreased expression of FABP3 mRNA] more ... CTD PMID:20470772 more ... endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of FABP3 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:69087 6480464 entinostat results in increased expression of FABP3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:69087 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP3 mRNA CTD PMID:27188386 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of FABP3 protein CTD PMID:24646710 ethanol increases expression ISO RGD:69088 6480464 Ethanol results in increased expression of FABP3 mRNA CTD PMID:30319688 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of FABP3 mRNA CTD PMID:25596134 ferroheme b increases expression ISO RGD:69088 6480464 Heme metabolite results in increased expression of FABP3 mRNA CTD PMID:19191707 flutamide increases expression EXP 6480464 Flutamide results in increased expression of FABP3 mRNA, Flutamide results in increased expression of FABP3 protein CTD PMID:17311803 , PMID:19299419 folic acid multiple interactions ISO RGD:69088 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 fructose multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of FABP3 protein CTD PMID:26930160 furan decreases expression ISO RGD:69088 6480464 furan results in decreased expression of FABP3 mRNA CTD PMID:24183702 genistein increases expression EXP 6480464 Genistein results in increased expression of FABP3 mRNA CTD PMID:17341692 genistein increases expression ISO RGD:69088 6480464 Genistein results in increased expression of FABP3 mRNA CTD PMID:32186404 genistein multiple interactions EXP 6480464 [Genistein co-treated with vinclozolin] results in increased expression of FABP3 mRNA CTD PMID:23160963 graphite increases expression ISO RGD:69088 6480464 Graphite results in increased expression of FABP3 mRNA CTD PMID:27440207 haloperidol affects response to substance ISO RGD:69088 6480464 FABP3 affects the susceptibility to Haloperidol CTD PMID:20181611 haloperidol increases expression ISO RGD:69087 6480464 Haloperidol results in increased expression of FABP3 protein CTD PMID:34122009 heme b increases expression ISO RGD:69088 6480464 Heme metabolite results in increased expression of FABP3 mRNA CTD PMID:19191707 ifosfamide decreases expression ISO RGD:69087 6480464 Ifosfamide results in decreased expression of FABP3 mRNA CTD PMID:25596134 iohexol increases expression ISO RGD:69087 6480464 Iohexol results in increased expression of FABP3 mRNA CTD PMID:29705293 iopamidol increases expression ISO RGD:69087 6480464 Iopamidol results in increased expression of FABP3 mRNA CTD PMID:29705293 isoprenaline increases expression ISO RGD:69088 6480464 Isoproterenol results in increased expression of FABP3 protein CTD PMID:19549929 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of FABP3 protein CTD PMID:19854236 , PMID:22878004 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of FABP3 protein CTD PMID:19826179 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of FABP3 mRNA CTD PMID:37077353 L-methionine multiple interactions ISO RGD:69088 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP3 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FABP3 gene CTD PMID:20938992 linoleic acid decreases expression ISO RGD:69087 6480464 Linoleic Acid results in decreased expression of FABP3 mRNA CTD PMID:15708366 maneb multiple interactions ISO RGD:69088 6480464 [Maneb co-treated with Paraquat] results in decreased expression of FABP3 mRNA CTD PMID:36117858 metaproterenol increases expression EXP 6480464 Metaproterenol results in increased expression of FABP3 protein CTD PMID:22878004 metformin increases expression EXP 6480464 Metformin results in increased expression of FABP3 mRNA CTD PMID:25596134 methamphetamine affects response to substance ISO RGD:69088 6480464 FABP3 affects the susceptibility to Methamphetamine CTD PMID:20181611 methamphetamine increases expression ISO RGD:69087 6480464 Methamphetamine results in increased expression of FABP3 mRNA CTD PMID:25290377 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of FABP3 mRNA CTD PMID:30047161 methylarsonic acid multiple interactions ISO RGD:69088 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA CTD PMID:34876320 methylisothiazolinone increases expression ISO RGD:69087 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of FABP3 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:69087 6480464 methylmercuric chloride results in increased expression of FABP3 mRNA CTD PMID:28001369 mitoxantrone increases expression EXP 6480464 Mitoxantrone results in increased expression of FABP3 protein CTD PMID:22878004 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of FABP3 mRNA, mono-(2-ethylhexyl)phthalate results in increased expression of FABP3 protein CTD PMID:12706301 , PMID:15647598 N-methyl-4-phenylpyridinium increases expression ISO RGD:69087 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FABP3 mRNA CTD PMID:24810058 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of FABP3 mRNA CTD PMID:17341692 nickel sulfate increases expression ISO RGD:69087 6480464 nickel sulfate results in increased expression of FABP3 mRNA CTD PMID:17382205 nickel sulfate decreases expression ISO RGD:69087 6480464 nickel sulfate results in decreased expression of FABP3 mRNA CTD PMID:22714537 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FABP3 mRNA CTD PMID:33484710 orciprenaline increases expression EXP 6480464 Metaproterenol results in increased expression of FABP3 protein CTD PMID:22878004 ozone decreases expression ISO RGD:69088 6480464 Ozone results in decreased expression of FABP3 mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:69088 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FABP3 mRNA CTD PMID:34911549 paclitaxel multiple interactions ISO RGD:69087 6480464 [FV-429 compound co-treated with Paclitaxel] inhibits the reaction [Oxygen deficiency results in increased expression of FABP3 protein] CTD PMID:34648812 panobinostat multiple interactions ISO RGD:69087 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:69087 6480464 panobinostat results in increased expression of FABP3 mRNA CTD PMID:26272509 paraquat multiple interactions ISO RGD:69088 6480464 [Maneb co-treated with Paraquat] results in decreased expression of FABP3 mRNA CTD PMID:36117858 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of FABP3 mRNA CTD PMID:19162173 , PMID:28511854 perfluorooctanoic acid increases expression ISO RGD:69088 6480464 perfluorooctanoic acid results in increased expression of FABP3 mRNA CTD PMID:23626681 , PMID:30711707 perfluorooctanoic acid multiple interactions ISO RGD:69088 6480464 Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of FABP3 mRNA] CTD PMID:23626681 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of FABP3 mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:69088 6480464 Phenobarbital affects the expression of FABP3 mRNA CTD PMID:23091169 phosphorus atom increases expression ISO RGD:69087 6480464 Phosphorus results in increased expression of FABP3 mRNA CTD PMID:17715259 phosphorus(.) increases expression ISO RGD:69087 6480464 Phosphorus results in increased expression of FABP3 mRNA CTD PMID:17715259 pioglitazone multiple interactions ISO RGD:69088 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FABP3 mRNA CTD PMID:27935865 pirinixic acid multiple interactions ISO RGD:69088 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of FABP3 mRNA more ... CTD PMID:15833283 more ... pirinixic acid increases expression ISO RGD:69088 6480464 pirinixic acid results in increased expression of FABP3 mRNA CTD PMID:15833283 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of FABP3 mRNA CTD PMID:19162173 , PMID:22484513 plumbagin multiple interactions EXP 6480464 plumbagin inhibits the reaction [Doxorubicin results in increased expression of FABP3 protein] CTD PMID:32691977 potassium chromate increases expression ISO RGD:69087 6480464 potassium chromate(VI) results in increased expression of FABP3 mRNA CTD PMID:17382205 potassium dichromate increases expression ISO RGD:69087 6480464 Potassium Dichromate results in increased expression of FABP3 mRNA CTD PMID:11678601 progesterone increases expression EXP 6480464 Progesterone results in increased expression of FABP3 mRNA CTD PMID:20726854 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of FABP3 mRNA CTD PMID:25905778 rotenone increases expression ISO RGD:69087 6480464 Rotenone results in increased expression of FABP3 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:69087 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate multiple interactions ISO RGD:69088 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA CTD PMID:34876320 sodium arsenite increases secretion EXP 6480464 sodium arsenite results in increased secretion of FABP3 protein CTD PMID:32736004 sodium arsenite multiple interactions ISO RGD:69088 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FABP3 mRNA, [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FABP3 mRNA CTD PMID:32045263 , PMID:34876320 sodium arsenite multiple interactions ISO RGD:69087 6480464 sodium arsenite results in increased expression of and affects the splicing of FABP3 mRNA CTD PMID:25879800 sodium dodecyl sulfate increases expression ISO RGD:69087 6480464 Sodium Dodecyl Sulfate results in increased expression of FABP3 mRNA CTD PMID:31734321 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of FABP3 mRNA CTD PMID:27257137 sodium nitrate multiple interactions ISO RGD:69088 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of FABP3 protein] CTD PMID:21251210 sulforaphane increases expression ISO RGD:69088 6480464 sulforaphane results in increased expression of FABP3 mRNA CTD PMID:30529165 sulforaphane decreases expression ISO RGD:69087 6480464 sulforaphane results in decreased expression of FABP3 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:69087 6480464 Sunitinib results in decreased expression of FABP3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:69088 6480464 Tamoxifen affects the expression of FABP3 mRNA CTD PMID:17555576 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of FABP3 mRNA CTD PMID:17630414 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of FABP3 mRNA CTD PMID:21515302 testosterone increases expression ISO RGD:69088 6480464 Testosterone results in increased expression of FABP3 mRNA CTD PMID:19693291 tetrachloromethane increases expression ISO RGD:69088 6480464 Carbon Tetrachloride results in increased expression of FABP3 mRNA CTD PMID:17484886 titanium dioxide decreases expression ISO RGD:69088 6480464 titanium dioxide results in decreased expression of FABP3 mRNA CTD PMID:23557971 toluene decreases expression EXP 6480464 Toluene results in decreased expression of FABP3 mRNA CTD PMID:22967744 topiramate decreases expression EXP 6480464 topiramate results in decreased expression of FABP3 mRNA CTD PMID:16979414 tributylstannane increases expression ISO RGD:69088 6480464 tributyltin results in increased expression of FABP3 mRNA CTD PMID:23428407 Tributyltin oxide increases expression ISO RGD:69088 6480464 bis(tri-n-butyltin)oxide results in increased expression of FABP3 mRNA CTD PMID:18958704 trichloroethene affects expression ISO RGD:69088 6480464 Trichloroethylene affects the expression of FABP3 mRNA CTD PMID:21135412 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FABP3 mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:69087 6480464 Triclosan results in decreased expression of FABP3 mRNA CTD PMID:30510588 troglitazone decreases expression ISO RGD:69087 6480464 troglitazone results in decreased expression of FABP3 mRNA CTD PMID:11162573 troglitazone increases expression ISO RGD:69087 6480464 troglitazone results in increased expression of FABP3 protein CTD PMID:9709955 tunicamycin decreases expression ISO RGD:69088 6480464 Tunicamycin results in decreased expression of FABP3 mRNA CTD PMID:17127020 valproic acid increases expression ISO RGD:69087 6480464 Valproic Acid results in increased expression of FABP3 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FABP3 mRNA CTD PMID:23160963 vinclozolin multiple interactions EXP 6480464 [Genistein co-treated with vinclozolin] results in increased expression of FABP3 mRNA CTD PMID:23160963 vitamin E increases expression ISO RGD:69087 6480464 Vitamin E results in increased expression of FABP3 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:69087 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP3 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:69087 6480464 vorinostat results in increased expression of FABP3 mRNA CTD PMID:26272509 vorinostat decreases expression ISO RGD:69087 6480464 vorinostat results in decreased expression of FABP3 mRNA CTD PMID:27188386
